$DXCM DEXCOM INC Insider Trading Week 10/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DEXCOM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DEXCOM INC in week 10/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 10 2017 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 77.55 | 3,208 | 248,782 | 97,815 | 101 K to 97.8 K (-3.18 %) |
Mar 10 2017 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 77.55 | 3,527 | 273,521 | 101,023 | 104.6 K to 101 K (-3.37 %) |
Mar 10 2017 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | D | 77.55 | 6,694 | 519,124 | 104,550 | 111.2 K to 104.6 K (-6.02 %) |
Mar 10 2017 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Grant | A | 0.00 | 27,510 | 28 | 111,244 | 83.7 K to 111.2 K (+32.85 %) |
Mar 10 2017 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Grant | A | 0.00 | 21,883 | 22 | 83,487 | 61.6 K to 83.5 K (+35.52 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 77.55 | 6,694 | 519,124 | 122,861 | 129.6 K to 122.9 K (-5.17 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 77.55 | 4,540 | 352,080 | 129,555 | 134.1 K to 129.6 K (-3.39 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 77.55 | 3,824 | 296,553 | 134,095 | 137.9 K to 134.1 K (-2.77 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Grant | A | 0.00 | 27,510 | 28 | 137,919 | 110.4 K to 137.9 K (+24.92 %) |
Mar 10 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Option Exercise | M | 8.85 | 3,000 | 26,550 | 10,939 | |
Mar 10 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 77.55 | 3,537 | 274,296 | 84,034 | 87.6 K to 84 K (-4.04 %) |
Mar 10 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | D | 77.55 | 6,161 | 477,789 | 87,571 | 93.7 K to 87.6 K (-6.57 %) |
Mar 10 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 77.67 | 3,000 | 233,002 | 93,732 | 96.7 K to 93.7 K (-3.10 %) |
Mar 10 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Buy | M | 8.85 | 3,000 | 26,550 | 96,732 | 93.7 K to 96.7 K (+3.20 %) |
Mar 10 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Grant | A | 0.00 | 23,134 | 23 | 93,732 | 70.6 K to 93.7 K (+32.77 %) |
Mar 10 2017 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 77.55 | 7,927 | 614,744 | 343,680 | 351.6 K to 343.7 K (-2.25 %) |
Mar 10 2017 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 77.55 | 15,853 | 1,229,410 | 351,607 | 367.5 K to 351.6 K (-4.31 %) |
Mar 10 2017 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | D | 77.55 | 13,211 | 1,024,521 | 367,460 | 380.7 K to 367.5 K (-3.47 %) |
Mar 10 2017 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Grant | A | 0.00 | 81,280 | 81 | 380,671 | 299.4 K to 380.7 K (+27.15 %) |
Mar 10 2017 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 77.55 | 14,512 | 1,125,414 | 454,559 | 469.1 K to 454.6 K (-3.09 %) |
Mar 10 2017 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 77.55 | 1,661 | 128,812 | 469,071 | 470.7 K to 469.1 K (-0.35 %) |
Mar 10 2017 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Grant | A | 0.00 | 30,887 | 31 | 470,732 | 439.8 K to 470.7 K (+7.02 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Grant | A | 0.00 | 28,761 | 29 | 132,663 | 103.9 K to 132.7 K (+27.68 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Abbey Donald | EVP Quality | Grant | A | 0.00 | 27,510 | 28 | 82,510 | 55 K to 82.5 K (+50.02 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Murphy Patrick Michael | VP, Legal Aff & Chf ... | Sell | D | 77.55 | 2,209 | 171,309 | 34,453 | 36.7 K to 34.5 K (-6.03 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Murphy Patrick Michael | VP, Legal Aff & Chf ... | Sell | D | 77.55 | 1,611 | 124,934 | 36,662 | 38.3 K to 36.7 K (-4.21 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Murphy Patrick Michael | VP, Legal Aff & Chf ... | Sell | D | 77.55 | 2,216 | 171,852 | 38,273 | 40.5 K to 38.3 K (-5.47 %) |
Mar 10 2017 | DXCM | DEXCOM INC | Murphy Patrick Michael | VP, Legal Aff & Chf ... | Grant | A | 0.00 | 11,361 | 11 | 40,489 | 29.1 K to 40.5 K (+39.00 %) |
Mar 08 2017 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Option Exercise | M | 7.31 | 31,890 | 233,116 | 0 | |
Mar 08 2017 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Sell | S | 78.13 | 31,890 | 2,491,572 | 17,246 | 49.1 K to 17.2 K (-64.90 %) |
Mar 08 2017 | DXCM | DEXCOM INC | SKYLER JAY S | Director | Buy | M | 7.31 | 31,890 | 233,116 | 49,136 | 17.2 K to 49.1 K (+184.91 %) |